Octave is an early-stage venture capital firm based in San Francisco that champions founders focused on enterprise data opportunities, including AI, data infrastructure, and privacy, at the earliest stages of company building.
Average disclosed round size is $19.1M (across 6 rounds with reported amounts).
Portfolio
7
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
AT
Axel Tan
Investment Director
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
8 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Bounti | Seed | $16M | Sep 2024 |
 ZeroEyes | Series B | $23M | Aug 2023 |
 Haus Analytics | Series A | $17M | Aug 2023 |
 Tonic | Series B | $35M | Sep 2021 |
| ZeroEyes | Series A | $20.9M | Aug 2021 |
 Finch Therapeutics | Growth | — | — |
 Springtail | Pre-Seed | $2.5M | — |
| FFinch Therapeutics Group | Growth | — | — |
Top Co-Investors
Haystack2 shared
Insight Partners2 shared
Bloomberg Beta2 shared
Alliance Ventures2 shared
Humboldt Fund2 shared
Avenir Growth2 shared
SymBiosis2 shared
OCV Partners2 shared
The Baupost Group2 shared
Willett Advisors2 shared
Baseline Ventures1 shared
Upside Partnership1 shared
XYZ Venture Capital1 shared
GGV Capital1 shared
Silicon Valley CISO Investments1 shared
Heavybit1 shared
Alpha Intelligence Capital1 shared
Begin Capital1 shared
Floodgate Fund1 shared
MS&AD Ventures1 shared
Last updated: 9 September 2026